U.S. regulators have temporarily halted use of Johnson & Johnson’s COVID-19 vaccine while they examine six cases of rare blood clots that have been reported in people who have received the shot.
AstraZeneca’s AZN, COVID-19 vaccine, which has not been authorized in the U.S., has faced similar concerns of rare blood clots, with some European countries halting use of...
Moleculin Biotech, a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced the engagement of IQVIA Biotech, a contract research organization (CRO) to manage the Company's effort to begin potential clinical trials of WP1122 for the treatment of COVID-19.
WP1122 was designed to...
Welcome Hyperspace Travelers,
I have some very bad news.. Covid-19 is not done yet, far from it actually.
I am under the diagnostic impression based on recent literature publication that their is going to be a freakish mutation somewhere in the spike protein mechanic increasing virility and death rate.
I have pathed Three Wavefunction Roots.
Each Root is...
I love JNJ long and believe that they are going to be fine with the recent COVID-related dip.
Their vaccine could do more damage than AstraZeneca's and governments will still buy it in order to herd the sheep.
You need to understand that JNJ is so much more than a vaccine company.
Expect this stock to go back up to the $167 level, as well as breaking the $170...
If you missed to short the results:
Then you should know that the indicators are bullish on most timeframes.
VXRT Vaxart makes vaccine doses in the form of convenient tablets using a proprietary technique that it calls VAAST (Vector-Adjuvant-Antigen Standardized...
Chembio Announces U.S. Commercial Launch of Diagnostic Tool to Differentiate COVID-19 and Flu.
Chembio Diagnostics, a leading point-of-care diagnostics company focused on infectious diseases, today announced the commercial launch of an FDA Emergency Use Authorization-approved, in-licensed rapid point-of-care COVID-19/Flu A&B test, for use in decentralized and...
The COVID-19 pandemic is holding the world, the economy and our health in a tight grip. So far Biontech/Pfizer have been successful with their vaccination, but as the virus mutates, it is unclear how effective the vaccination is. Many COVID-19 infected patients have to be hospitalized with a need for mechanical ventilation and that is where Humanigen plays a major...
The price of Brent crude oil fell from $ 70 in early March to $ 64 per barrel, a drop of 8.5%.
📉Factors that contributed to lower oil prices were delays in vaccination in most countries.
📉Delayed vaccine supplies and local lockdowns continue to stand in the way of a full resumption of economic activity.
📉📄Also the OPEC agreement on April 1, where the...
HGEN has two RCTs with imminent data, one of them the company's own, the other the NIH's ACTIV-5 Trial. The company is preparing to file an EUA for Lenzilumab pending the trials' completion. Announcements are expected in the week starting March 29, two days from now. Nomis Bay, a fund that had held a large stake of HGEN since it was trading in single digits...
Best Penny Stocks to buy and watch in April 2020 : URGN
😊Please LIKE & FOLLOW for more VIP Hunters signals in Forex , penny stocks and cryptocurrency
Date of the Release : URGN
FDA date of approval - 18th of April
What’s the real story :
The beauty of Penny stock that I trade in particular , They are ALL pharmaceutical companies. The AMAZING part is 90%...
Novacyt big fall today, don't worry medium long term still hasn't broken level but keep an eye out for volatility next week we recommend that you buy if you can to the level you think is appropriate, it is a company that in the medium term has high expectations L.E.D Capital Management has investments and has had large investments in ALNOV, continuing to rely on...
WMT flopped its fourth quarter earnings in 2020 announcing -.74 cents a share. I expect a report with a lot more strength with integration of E-commerce into it online store models as well as less fear surrounding COVID-19 creating boost in sales. With only 1% of shares floating short, The slow grind up, which has been evident since the middle of March, is likely...
Levels -
Buy - Any dip the CMP or it breaks above 628
T1 - 645
T2 - 700
SL - 610
The undertone of the Pharma sector is bullish amid the second wave of COVID-19 hitting India. Sun Pharmaceuticals has the largest market capitalization and is currently trading at half the price of its all-time high which was close to 1200. The stock has seen a major correction from...
Humanigen Reports Positive Phase 3 Topline Results Demonstrating That Lenzilumab™ Improves Survival Without Need for Mechanical Ventilation in Hospitalized Patients With COVID-19.
Lenzilumab improved the relative likelihood of survival without need for invasive mechanical ventilation (IMV) by 54%, achieving the primary endpoint of the Phase 3 study
Clinical...
